R 0021/09 of 19.03.2010
- European Case Law Identifier
- ECLI:EP:BA:2010:R002109.20100319
- Date of decision
- 19 March 2010
- Case number
- R 0021/09
- Petition for review of
- T 1753/06 2009-05-06
- Application number
- 01954058.2
- IPC class
- C07D 209/42
- Language of proceedings
- French
- Distribution
- Distributed to board chairmen and members (B)
- Download
- Decision in French
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Forme cristalline alpha du sel de tert-butylamine du perindopril
- Applicant name
- Les Laboratoires Servier
Autres Parties :
Quimica Sintetica. S.A.
NORTON HEALTHCARE LTD
Glenmark Pharmaceuticals Ltd
POLPHARMA
MIESZKOWSKA, Agnieszka, AMCA Consulting
Hetero Drugs Limited
Ratiopharm GmbH - Opponent name
- -
- Board
- -
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 112aEuropean Patent Convention Art 113European Patent Convention Art 23(3)European Patent Convention R 106European Patent Convention R 109High Court of Justice - Court of Appeal (Civil Division): Actavis UK Limited v. Novartis AG (A3/2009/0675)Rules of procedure of the Boards of Appeal Art 17(2)
- Keywords
- Violation fondamentale de procédure: non respect du droit de se défendre - Art. 113 CBE [non]
Requête en révision - manifestement non fondée - Catchword
- -
- Cited cases
- T 0452/91
DISPOSITIF
Par ces motifs, il est statué comme suit :
La requête en révision est rejetée comme manifestement non fondée.